Medical/Pharmaceuticals
The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA
CHENGDU, China, May 8, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company") announced that the sNDA (the "Application") for the Company's TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) was accepted for review ...
2026-05-08 19:29
4562
What Sets Medtec China Apart from Other Medical Device Manufacturing Expos
SHANGHAI, May 8, 2026 /PRNewswire/ -- Building a successful medical device
requires precise engineering, reliable materials, and a resilient supply chain.
Finding the right partners to bring your vision to life is a major challenge.
TheMedtec China trade show
2026-05-08 19:21
4430
For the Reasons that Matter: A Multi-Spotlight Campaign Puts Adult Respiratory Health in Focus
JAKARTA, Indonesia, May 7, 2026 /PRNewswire/ -- In conjunction with World Immunization Week, Pfizer Indonesia, together with healthcare professionals has launched "For the Reasons that Matter", a public awareness campaign focused on adult respiratory health. Rolling out simultaneously across Indo...
2026-05-07 23:05
3284
Fertility patients vulnerable to social media overload of misleading data where evidence and algorithms collide
BEIJING, May 7, 2026 /PRNewswire/ -- Patient information overload dominated by misleading social media and marketing is causing patients experiencing infertility to have unrealistic expectations about treatment success often resulting in psychological distress. "Never before have patients had ...
2026-05-07 14:53
2763
Move towards global consensus guidelines on surrogacy with mounting concerns over human rights violations
BEIJING, May 7, 2026 /PRNewswire/ -- World leaders in assisted reproductive technology are finalising global consensus guidelines on minimal standards in surrogacy to address mounting concerns about severe human rights violations. The standards will attempt to tackle inconsistent or inadequate ...
2026-05-07 09:00
2942
AID 2026 to Showcase Booming Opportunities in Silver Economy
SHANGHAI, May 7, 2026 /PRNewswire/ -- International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare, Shanghai 2026 (hereinafter referred to as AID 2026), widely recognized as China's leading event for the senior care and silver economy sectors, will be held on June 4–6 at Shangh...
2026-05-07 09:00
2792
ABEC Expands Process Sciences Group to Strengthen Bioprocess Optimization Capabilities
BETHLEHEM, Pa., May 6, 2026 /PRNewswire/ -- ABEC, a global leader in bioprocess engineering solutions, announced the expansion of itsProcess Sciences group, expanding its ability to help biopharmaceutical manufacturers accelerate development, reduce risk, and improve productivity across the biopr...
2026-05-06 22:09
2919
Ribo and Boehringer Ingelheim further progress their siRNA program for metabolic dysfunction-associated steatohepatitis (MASH)
SUZHOU, China and MÖLNDAL, Sweden, May 6, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB ("Ribo", HKEX: 6938) today announced the achievement of a further milestone. This marks the third key milestone achieved in the research collaboration with Boehringer ...
2026-05-06 19:32
3093
China Medical Exhibition 2026: Industries, Products, and Innovations to Watch
SHANGHAI, May 6, 2026 /PRNewswire/ -- The medical device industry moves fast.
To stay competitive, you must source the best materials and adopt the latest
manufacturing technology before your rivals do. Medtec China
2026-05-06 17:53
2689
The GBA Healthcare Group and Adventist Health Hong Kong Forge Strategic Partnership for Seamless Specialty Care
Pooling Guangdong–Hong Kong clinical strengths to deliver an end-to-end cross-border care ecosystem spanning direct billing, fast-track referrals and precision specialty matching HONG KONG, May 6, 2026 /PRNewswire/ -- The GBA Healthcare Group ("GBAH") and Adventist Health Hong Kong ("AHHK") toda...
2026-05-06 15:00
3297
MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026
GUANGZHOU, China, May 6, 2026 /PRNewswire/ -- MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas, announced positive results from its Phase II clinical trial of QA102 in patients with intermediate dry ...
2026-05-06 08:28
3548
Ascletis to Present Data on Multiple Programs at the 33rd European Congress on Obesity (ECO 2026)
HONG KONG, May 6, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today poster presentations highlighting multiple programs at the 33rd European Congress on Obesity (ECO 2026), taking place May 12-15, 2026 in Istanbul, Türkiye. The presentations include a poster on...
2026-05-06 08:10
2835
Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
* PEDMARQSI® is now TGA registered in Australia for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to <18 years of age with localised, non-metastatic, solid tumours * TGA registration provides an approved treatment option in an area of significant unmet me...
2026-05-06 05:01
2881
AI Model Analyses Body Composition to Predict Health Risks
OAK BROOK, Ill., May 5, 2026 /PRNewswire/ -- Researchers used AI to analyze whole-body MRI scans from more than 66,000 participants to create the most detailed reference map to date of how fat and muscle are distributed in the human body across age, sex and height. The study was published today i...
2026-05-05 22:00
2380
Hidden Muscle Fat Poses Danger to Heart, Metabolism
OAK BROOK, Ill., May 5, 2026 /PRNewswire/ -- Using a deep learning model to analyze the composition of large muscles on MRI, German researchers found that the proportions of intermuscular fat and lean muscle mass were associated with high blood pressure and unhealthy lipid and blood sugar levels....
2026-05-05 22:00
2293
BostonGene Receives Frost & Sullivan's 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
Recognition highlights BostonGene's leadership in improving drug development
decisions,
reducing risk and accelerating patient impact
SAN ANTONIO, May 5, 2026 /PRNewswire/ -- Frost & Sullivan
2026-05-05 22:00
3419
3Shape appoints new Chief Financial Officer
COPENHAGEN, Denmark, May 5, 2026 /PRNewswire/ -- 3Shape today announced the appointment of Stefan Kratzer as Chief Financial Officer effective 5 May. He will join the Senior Leadership Team and report directly to CEO Jacob Paulsen. The appointment ensures strong leadership continuity, with an exp...
2026-05-05 19:26
2541
Cleveland Clinic, RIKEN, and IBM Model a 12,635-Atom Protein - the Largest Known to Be Simulated with Quantum Computers
Milestone simulation of biologically meaningful molecules expands
quantum-centric supercomputing's role as a scientific tool
YORKTOWN HEIGHTS, N.Y. and CLEVELAND, May 5, 2026 /PRNewswire/ -- Scientists
at Cleveland Clinic, RIKEN, and IBM (NYSE:IBM
2026-05-05 12:18
3474
Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)
Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf Treg therapy, in patients with steroid-refractory GVHD HOUSTON, May 5, 2026 /PRNewswire/ -- Cellenkos®, Inc., a clinical stage biotechnology company, pioneering allogeneic, ...
2026-05-05 05:16
2839
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
MELBOURNE, Australia and INDIANAPOLIS, Ind., May 5, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces the publication of a new independent analysis of Phase 3 ZIRCON trial data in European Urology[1], demonstrating that TLX250‑Px (Zircaix®[2], 89 Z...
2026-05-05 05:00
3413
Week's Top Stories
Most Reposted
Tonik Becomes the First Standalone Digital Bank in the Philippines to Achieve Profitability
[Picked up by 297 media titles]
2026-05-12 10:15
Visa amps up the music as Official Payment Partner for the Asia leg of The Weeknd's 'After Hours Til Dawn' Stadium Tour
[Picked up by 295 media titles]
2026-05-11 16:20
Avnet and HKSTP Invite Global Startups to New AI Hardware Launchpad
[Picked up by 292 media titles]
2026-05-12 10:00Hong Leong Bank Awarded Best Managed Bank in Malaysia by The Asian Banker, Group MD/CEO Kevin Lam Named Best Bank CEO in Malaysia
[Picked up by 285 media titles]
2026-05-15 17:00
Peach Blossoms Celebrates Three Massive Wins - Black Pearl Restaurant Guide 2026, Asia's 50 Best Restaurants 2026 Extended List and Tatler Best 20 Restaurants in Singapore 2026
[Picked up by 285 media titles]
2026-05-12 14:00
Most Read
Visa amps up the music as Official Payment Partner for the Asia leg of The Weeknd's 'After Hours Til Dawn' Stadium Tour
2026-05-11 16:20
6465
CSTS Enterprises Launches "Generation C" Initiative -- A Ground‑Breaking International Football Extravaganza, Debuting This May in Hunan, China
2026-05-15 21:16
5234
Zendure Launches PowerHub, Europe's First Plug-In HEMS Hub That Turns Any Solar Home Into a Whole-Home Energy Ecosystem
2026-05-11 23:36
5173
NYSE Content Update: Eli Lilly to Celebrate 150 Years of Scientific Innovation
2026-05-11 21:16
5136
